Naysayers may harp on the low market valuations of stem cell companies, but Geoff MacKay has an insider's perspective.
http://seekingalpha.com/article/1349371-what-will-it-take-for-stem-cell-companies-to-close-the-valuation-gap?source=feed
http://seekingalpha.com/article/1349371-what-will-it-take-for-stem-cell-companies-to-close-the-valuation-gap?source=feed
No comments:
Post a Comment